Keywords: s-p, blocked, subutex, generic, france, expiry, patent

S-P "blocked Subutex generic" in France

Article | 17 December 2007

The expiry of the patent on Schering-Plough's psychotropic drug Subutex (buprenorphine) has generated a commercial battle in the French market ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Schering Plough

Schering-Plough

Go to company listing

Related Drugs

Buprenex

Buprenorphine

Go to drug listing